Early Prediction of Nonresponders to Treatment with Interferon Alpha-2B and Ribavirin in Patients with Chronic Hepatitis C
BACKGROUND: Treatment of chronic hepatitis C virus (HCV) infection with interferon alpha-2b and ribavirin is costly in terms of side effects, medical resources and drug costs. Furthermore, less than 50% of patients overall have a sustained virological response (SVR).
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2003-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2003/351816 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832552660688961536 |
|---|---|
| author | Louis WC Liu George Tomlinson Tony Mazzulli Alison Murray Jenny Heathcote |
| author_facet | Louis WC Liu George Tomlinson Tony Mazzulli Alison Murray Jenny Heathcote |
| author_sort | Louis WC Liu |
| collection | DOAJ |
| description | BACKGROUND: Treatment of chronic hepatitis C virus (HCV) infection with interferon alpha-2b and ribavirin is costly in terms of side effects, medical resources and drug costs. Furthermore, less than 50% of patients overall have a sustained virological response (SVR). |
| format | Article |
| id | doaj-art-9d8ec1150be14a4b9e2a92e675fd0219 |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2003-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-9d8ec1150be14a4b9e2a92e675fd02192025-02-03T05:58:08ZengWileyCanadian Journal of Gastroenterology0835-79002003-01-0117848348710.1155/2003/351816Early Prediction of Nonresponders to Treatment with Interferon Alpha-2B and Ribavirin in Patients with Chronic Hepatitis CLouis WC Liu0George Tomlinson1Tony Mazzulli2Alison Murray3Jenny Heathcote4Department of Medicine, McMaster University, Hamilton, Ontario, CanadaUniversity Health Network, Department of Clinical Epidemiology, CanadaToronto Medical Labs/Mount Sinai Hospital, Department of Microbiology, Toronto, Ontario, CanadaGlaxo SmithKline, Greenford, UKUniversity Health Network, Department of Medicine, Toronto, Ontario, CanadaBACKGROUND: Treatment of chronic hepatitis C virus (HCV) infection with interferon alpha-2b and ribavirin is costly in terms of side effects, medical resources and drug costs. Furthermore, less than 50% of patients overall have a sustained virological response (SVR).http://dx.doi.org/10.1155/2003/351816 |
| spellingShingle | Louis WC Liu George Tomlinson Tony Mazzulli Alison Murray Jenny Heathcote Early Prediction of Nonresponders to Treatment with Interferon Alpha-2B and Ribavirin in Patients with Chronic Hepatitis C Canadian Journal of Gastroenterology |
| title | Early Prediction of Nonresponders to Treatment with Interferon Alpha-2B and Ribavirin in Patients with Chronic Hepatitis C |
| title_full | Early Prediction of Nonresponders to Treatment with Interferon Alpha-2B and Ribavirin in Patients with Chronic Hepatitis C |
| title_fullStr | Early Prediction of Nonresponders to Treatment with Interferon Alpha-2B and Ribavirin in Patients with Chronic Hepatitis C |
| title_full_unstemmed | Early Prediction of Nonresponders to Treatment with Interferon Alpha-2B and Ribavirin in Patients with Chronic Hepatitis C |
| title_short | Early Prediction of Nonresponders to Treatment with Interferon Alpha-2B and Ribavirin in Patients with Chronic Hepatitis C |
| title_sort | early prediction of nonresponders to treatment with interferon alpha 2b and ribavirin in patients with chronic hepatitis c |
| url | http://dx.doi.org/10.1155/2003/351816 |
| work_keys_str_mv | AT louiswcliu earlypredictionofnonresponderstotreatmentwithinterferonalpha2bandribavirininpatientswithchronichepatitisc AT georgetomlinson earlypredictionofnonresponderstotreatmentwithinterferonalpha2bandribavirininpatientswithchronichepatitisc AT tonymazzulli earlypredictionofnonresponderstotreatmentwithinterferonalpha2bandribavirininpatientswithchronichepatitisc AT alisonmurray earlypredictionofnonresponderstotreatmentwithinterferonalpha2bandribavirininpatientswithchronichepatitisc AT jennyheathcote earlypredictionofnonresponderstotreatmentwithinterferonalpha2bandribavirininpatientswithchronichepatitisc |